The weeklong Antibody Therapeutics pipeline reveals the exciting developments in next-generation antibody therapeutics, including Antibody-Drug Conjugates, Bispecific Antibody Therapeutics, and Cancer Immunotherapies. Along with engineering breakthroughs, this pipeline also explores successful R&D strategies, translational case studies, clinical results, and efficacy data for these promising molecules as they seek to conquer cancer and other diseases and promote human health.


January 20-21

Engineering Next-Generation Cancer Immunotherapies

January 21-22

Antibody-Drug Conjugates

January 23-24

Bispecific Antibody Therapeutics


Keynote Speakers

Shahram Salek-Ardakani, PhD, Senior Director, Cancer Immunology Discovery, Pfizer


Rakesh Dixit, PhD, DABT, President & CEO, Bionavigen, LLC


Partha S. Chowdhury, Senior Director, Biologics Research, Sanofi Genzyme


Register

2020 Conferences & Training Seminars